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ABSTRACT 
Genomics has become a pivotal technology for understanding emerging outbreaks of infectious diseases.  A 
wide range of technologies and strategies for pathogen genome enrichment and sequencing are being used by 
laboratories and institutes, resulting in different analytical procedures for generating genome sequences and 
resulting in non-standard entries of varying quality into public repositories. A standardized analytical process 
for genome sequence generation, particularly for outbreaks such as the ongoing COVID-19 pandemic, are 
critical to provide scientists with a solid genomic basis for epidemiology analyses and for making 
well-informed decisions. To address this challenge, we have developed a web platform (EDGE COVID-19) to 
run standardized workflows for reference-based genome assembly and to perform further analysis of Illumina 
or Oxford Nanopore Technologies data for SARS-CoV-2 genome sequencing projects. Given a raw Illumina 
or Oxford Nanopore FASTQ read file, this web platform automates the production of a SARS-CoV-2 genome 
that is ready for submission to GISAID or GenBank. EDGE COVID-19 is open-source software that is 
available as a web application for public use at ​https://covid19.edgebioinformatics.org​, and as a Docker 
container at ​https://hub.docker.com/r/bioedge/edge-covid19​ for local installation. 
INTRODUCTION  
Genome sequencing is playing an increasingly critical role in understanding disease outbreaks. 
Highlighting this trend, public health laboratories and scientists around the world have been sequencing strains 
of SARS-CoV-2, a positive stranded ~29kb RNA virus and the etiological agent responsible for the global 
COVID-19 pandemic. In under 6 months, more than 40,000 genomes have been sequenced and made publicly 
available via genome repositories such as GISAID ​(Shu and McCauley 2017)​ and GenBank ​(Clark et al. 
2016)​. Open access to these genomes has enabled scientists to design and refine diagnostic assays for the virus 
(Jansen van Rensburg et al. 2016)​, monitor its evolution ​(Petit and Read 2018)​, and track its movement within 
communities and around the globe ​(Hadfield et al. 2018)​. 
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Multiple approaches have been applied to obtain SARS-CoV-2 genome sequences, including 
enriching for the virus prior to sequencing or performing deep, random, ‘shotgun’ sequencing of clinical 
samples. One effort helping to standardize these sequencing procedures comes from the international ARTIC 
network, that provides end-to-end instructions for the Oxford Nanopore Technologies (ONT) sequencing 
platforms. Currently in its third revision, this protocol outlines a multiplex PCR amplicon sequencing 
approach for SARS-CoV-2 (​https://artic.network/ncov-2019​). Detailed command-line instructions for 
generating the consensus sequence of the viral genome from  “raw” sequencing data is available on their 
website as well. The wet-lab protocols have also been adapted for Illumina sequencing (​Sevinsky, et al. 2020)​, 
allowing a wider range of laboratories and institutes to enrich for and sequence SARS-CoV-2. Despite these 
efforts, there is no single, standardized protocol and there remain a number of sequencing strategies that 
continue to be employed. 
In addition to having multiple sequencing strategies available, routine SARS-CoV-2 genome 
sequencing by laboratories is further challenged by the complexity of downstream bioinformatics data 
processing. There is a distinct need for a standardized, easy-to-use, GUI-based, web application that covers the 
basic bioinformatics analyses required to generate genomes for submission to public repositories that works 
for all these sequencing protocols. Due to a lack of standardization, there is significant variability in the 
quality of publicly available genome sequences, which can potentially confound downstream analyses. The 
importance of standardized procedures for generating the genomes that are critical for robust interpretation of 
SARS-CoV-2 evolution and epidemiology has, in part, motivated the creation of ​SPHERES ​(​SARS-CoV-2 
Sequencing for Public Health Emergency Response, Epidemiology and Surveillance​)​,​ a new open genomics 
consortium to coordinate SARS-CoV-2 sequencing across the United States.  
    A basic, standardized, bioinformatic, genome assembly workflow for reads obtained from clinical samples 
should, at minimum, include: per-read data quality assessment, background read removal/filtering (e.g. human 
data), per-read trimming, and genome sequence assembly (either ​de novo​, or, more traditionally, 
reference-based). Submission of genome sequences to public repositories further requires sample and 
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 sequencing metadata (e.g. sample collection date, patient age, gender, geographic location, etc.) that also 
requires standardization. In addition to standardization, it is essential to reduce the complexity of the process 
of genome assembly for scientists during an outbreak. While there are many open-source software options for 
each individual bioinformatic step, most of these can only be executed from the command-line in a Linux 
environment. This software complexity presents a major challenge to most bench scientists who may not have 
extensive training in bioinformatics, and can result in ​ad hoc​ procedures for deciding the final genome 
sequence of an individual sample. Finally, the lack of automated genome sequence submission to public 
repositories results in additional complexity, and increases the chance of introducing human errors that can 
further confound downstream analyses. T​his barrier also delays timely deposition and slow down follow-on 
analyses. 
RESULTS 
     Here we present EDGE COVID-19, a user-friendly web platform that enables rapid, automated and 
standardized processing of  FASTQ reads, from either Illumina or ONT platforms, and the generation of a 
consensus SARS-CoV-2 genome sequence. EDGE COVID-19 records sample and sequencing metadata 
sufficient for submission to GenBank and GISAID, with an automated process available for  GISAID 
submission. EDGE COVID-19 also includes single nucleotide polymorphism (sample to reference 
differences) and variant (within sample differences) analysis modules. Results are presented as tables and as 
an interactive genome browser within the GUI. This platform is freely available as a Docker container for 
local installation and as a public web service, where users can register for accounts, upload data, run analyses, 
and download results. This platform also enables direct submission of the genome and metadata to the 
GISAID genome repository. By default, a short description of the method used for calling the consensus is 
placed within the metadata form, while other metadata fields are entered manually by the user. 
Validation of the workflow 
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Datasets from the NCBI Sequence Read Archive (SRA) were used to validate the EDGE COVID-19 
default workflow. As of May 4, there were 45 (last accessed on May 4, 2020) BioProjects in NCBI 
representing over 4,500 COVID-19-related SRA datasets, from a variety of institutes, generated using a range 
of sample preparation methods, sequencing strategies, and sequencing platforms.  Of these BioProjects, only 
12 were able to be connected via metadata to corresponding SARS-CoV-2 genomes found in either GenBank 
or GISAID.  We selected the SRA datasets from the FDA-ARGOS BioProject, as well as one example dataset 
for all other BioProjects with an associated SARS-CoV-2 genome sequence. The FDA-ARGOS database is 
ideal for validation, as it comprises a collection of quality-controlled and curated reference genomes intended 
to support diagnostic use and regulatory decisions, and are therefore ideal for validation purposes ​(Sichtig et 
al. 2019)​. ​Supplementary Table 1​ contains full descriptions of the datasets and our validation result 
summaries. All of the datasets and their analyses are hosted on the 
https://edge-covid19.edgebioinformatics.org​ website, and can be re-run at any time by any registered user by 
simply providing the same SRA accession number as input and using default parameters. The SARS-CoV-2 
Wuhan Hu-1 genome (​NC_045512.2​) is used as the default reference, and a consensus for each SRA dataset 
was calculated using the default parameters in the EDGE COVID-19 workflow (for details, see ​Methods​). All 
differences (Single Nucleotide Polymorphisms or SNPs, insertions/deletions or indels, gaps, and ambiguous 
bases) between the consensus genomes from EDGE COVID-19 and the reference genome used to call the 
consensus were verified manually by examining the underlying read support. For validation purposes,  the 
corresponding GenBank or GISAID genome for each SRA dataset was also aligned, using NUCmer ​(Kurtz et 
al. 2004)​ to the Wuhan Hu-1 genome to compare differences, as well as directly compared to the consensus 
genome generated by our workflow. All differences were analyzed by examining the underlying read support.  
While some differences were observed, these comparisons demonstrate that the EDGE COVID-19 
workflow automatically produces genomes that are of equal quality to those found in the public repositories. 
For example, in terms of SNPs, no differences between any of the EDGE COVID-19 consensus genomes 
versus GenBank/GISAID repository genomes were found, with the singular exception of one ONT dataset 
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 (​SRR11483109​) generated using the ARTIC protocol (V1). Although our workflow and the genome in 
GISAID (GISAID: EPI_ISL_416419) shared the same four SNPs when compared to the Wuhan-Hu-1 
reference genome, our workflow detected one additional SNP at reference position 17747. Greater than 85% 
of the 1391 reads that map to this position support the single C to T non-synonymous (proline to leucine) 
change in the helicase ORF1ab gene. The reason this may have been missed in the originally deposited 
genome is that this SNP is located within one of the PCR primers employed in the enrichment protocol. 
Insufficient primer trimming can result in missing genomic differences in primer regions. 
The only indel identified by the EDGE COVID-19 workflow with the examined datasets, was a 
3-nucleotide codon (Lysine) deletion in the Orf1ab polyprotein that was also captured in the repository 
genome (GenBank: MT039887.1). Almost all differences between the EDGE COVID-19 consensus and the 
repository genomes were found with respect to gaps (i.e., missing sequences compared with the reference) and 
ambiguous bases (Note: entries in the repositories do not distinguish these two, and only report N’s, while 
EDGE COVID-19 specifies gaps as lower-case n’s and ambiguities as upper-case N’s).  Only one dataset 
(​SRR11140749​), sequenced by random PCR, covered the full length of the genome, while all other datasets 
had at least one gap at one end of the genome, confirming that the ends of genomes are not targeted with 
amplicon approaches, and not as well represented as the middle of the genome with shotgun or capture data.  
The largest differences in gaps reported were observed within the viral genome. Because “gaps” in the 
EDGE COVID-19 workflow (reported as lower-case n’s in the consensus)  do not have any underlying reads, 
we infer that sequence from a reference genome was used to fill in the gap prior to deposition in a genome 
repository. As an example,  for the SARS-CoV-2 genome recovered from a tiger (​SRR11587600​) and 
sequenced using an ARTIC protocol with an Illumina platform, our workflow introduced a large gap (as a 
stretch of 251 n’s, whose coordinates matched the ARTIC amplicon primer set #64), while the deposited 
genome (GISAID: EPI_ISL_420293) displayed no gaps in this region. Upon inspection, this 251nt in the 
deposited sequence is identical to the Wuhan Hu-1 reference genome, despite the fact that no reads were found 
to map to this region of the genome. This suggests that the sequence from a reference genome was likely used 
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to fill in this gap. Similar observations were made for several other datasets, including other ARTIC protocols 
sequenced on Illumina (SRR11563872) or ONT platforms (SRR11397722), a similar CDC amplicon 
enrichment protocol sequenced with ONT (SRR11637325), and shotgun sequencing datasets sequenced using 
Illumina (SRR11786915, SRR10903401, SRR11092057) or ONT (SRR11178057). 
A similar trend was found with nucleotides labeled as “ambiguous” using the EDGE COVID-19 
workflow (positions with either insufficient coverage or when there is allelic variation with no dominant 
allele; output as upper-case N’s in the consensus). In most cases, the EDGE COVID-19 workflow, with a 
five-fold (5X) coverage cutoff, was more conservative at the ends of the genome, where there is generally less 
data to support a specific nucleotide call. Additional differences were also found within the genome, where 
our workflow was again more conservative. For example, using the ​SRR11397722​ ONT dataset (V1 ARTIC 
amplicon protocol), the EDGE COVID-19 workflow reported 269 ambiguities in two regions within the 
genome. One of the two locations, from positions 22878 to 23144 (267 nucleotides, corresponding to ARTIC 
amplicon #76), was covered in its entirety by only 4X, or less coverage, which our workflow deemed 
insufficient to call a consensus using the default cutoff of 5X. Low coverage of some amplicons in multiplex 
amplicon sequencing schemes are known to occur, and have indeed even been previously reported for this 
same ARTIC amplicon #76 ​(Itokawa et al. 2020)​. While a majority-rules consensus calling algorithm almost 
always agrees with the reference Wuhan Hu-1 genome in these regions, this is not always the case in such low 
coverage areas. Because protocols for calling consensus genomes are not part of standard metadata entries, the 
algorithm used to determine the consensus in existing deposited genomes remains unknown and thus it is not 
possible to tell, without rigorous analysis of raw supporting data, whether the genomes are indeed complete as 
reported or if sections have been filled in with a reference sequence.  
We found a notable exception in ​SRR11483109​ (from the Yale School of Public Health group), that 
was processed with more stringent parameters and has more dropouts (genomic regions with N’s) in the 
corresponding genome (GISAID: EPI_ISL_416419) compared with the sequence produced by the default 
EDGE COVID-19 workflow. Six different regions containing 200-300 N’s were reported in the GISAID 
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 genome and consist of the unique portions of ARTIC amplicons 9, 18, 45, 64, 67, and 76. Only two of these 
regions (amplicons 18 and 64) were also labeled as gaps using the default EDGE COVID-19 workflow. In an 
online preprint of their work, the Yale group describe using a 20 fold coverage cutoff value for calling their 
consensus sequences ​(Fauver et al. 2020)​, while the default for the EDGE COVID-19 workflow is five-fold. 
Indeed, further verification of the other four reported gap regions in the deposited genome showed that three 
of them (amplicons 9, 45 and 67) were covered at an average of 10-16 fold coverage, with only a single 
ambiguous nucleotide reported in amplicon 9 at position 2625. Amplicon 76 only had 1X fold coverage, and 
was reported by EDGE COVID-19 as nine short (<10nt) gaps interspersed among 248 ambiguous nucleotides. 
Ironically, while stringent fold-coverage parameters were used for calling a consensus genome, this particular 
genome was the only genome we observed to have missed a SNP (see above). Together, these examples 
provide a survey of genome consensus calling techniques and the variability among publicly available 
genomes with associated SRA read sets. 
CONCLUSION/DISCUSSION 
While genomes are being rapidly sequenced and provided to the public during infectious disease 
outbreak scenarios, such as with the COVID-19 pandemic, it is most often unclear how the genomes 
themselves have been generated. This is further complicated by the number of different sequencing protocols 
available, the number of different bioinformatics strategies being applied, the number of different groups, with 
diverse backgrounds, generating the data, and the dearth of publicly-available raw data to help validate the 
accuracy of genomes. Indeed, the above examples illustrate a number of inconsistencies in publicly available 
genomes, highlighting the need for a consistent analytical workflow for generating consensus sequences, 
particularly during a pandemic, when genome analysis is routinely used for epidemiology and can impact 
response strategies. The EDGE COVID-19 web platform is a robust, standardized, user-friendly 
bioinformatics workflow designed for the global community in response to the ongoing COVID-19 pandemic. 
EDGE COVID-19 can help produce submission-ready, high-quality genomes from raw Illumina or ONT 
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sequencing data generated from a range of protocols. The source code is being actively maintained and 
developed, with a commitment to adopting community-agreed upon standards (such as those being discussed 
and implemented within the SPHERES consortium). The use of a software container to ease local installation 
and implementation, and the ability to execute EDGE COVID-19 via command line or via a web-based 
interface are features designed to lower the barrier for widespread adoption. While this workflow is one of 
many possible examples of a standardized process for generating consensus genomes, it is clear that adoption 
of this type of standardized workflow by the scientific and public health communities during an outbreak 
would facilitate the downstream use and interpretation of these genomes.  
METHODS 
Implementation of EDGE COVID-19 
EDGE COVID-19 is a tailored version of the more generic open source, EDGE bioinformatics 
platform  ​(Li et al. 2017)​, which was developed to democratize genomics analysis and make available 
complex bioinformatic tools to non-experts. EDGE COVID-19 is focused on generating high quality 
SARS-CoV-2 genomes from raw sequencing data, thus is stripped of non-essential bioinformatic tools and 
modules, but instead includes strict default reference genome alignment and reference-guided consensus 
generation.  This COVID-19 specific workflow drives a series of best-practice, open-source bioinformatics 
software to aid in the reconstruction of complete genomes of SARS-CoV-2 from raw shotgun, or 
SARS-CoV-2 enriched, Illumina or ONT sequencing data (including those generated using the popular 
ARTIC protocols). Users can input their own Illumina or ONT sequencing FASTQ files, or identify datasets to 
be automatically obtained directly from the NCBI Sequence Read Archive (SRA) or European Nucleotide 
Archive (ENA) for analyses. The default workflow (Figure 1) of EDGE COVID-19 consists of data quality 
control and filtering, read mapping to a reference genome sequence, generation of a consensus-based genome, 
variant analysis, and with post-processing steps to provide web-based views of the results. Detailed parameters 
for each step can be accessed from ​online documentation​. 
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 Initially, the data is processed for quality control using FaQCs v2.09 ​(Lo and Chain 2014)​ for either 
Illumina or ONT reads; ONT reads are additionally processed using Porechop v0.2.3 ​(Wick 2017)​ for adapter 
trimming. Removal of human reads by reference mapping is provided as an optional feature. Data QC is 
followed by mapping the high quality reads to a reference genome using either bowtie2 v2.4.1 ​(Langmead and 
Salzberg 2012)​, BWA v0.7.12 ​(Li and Durbin 2009)​ (default), or minimap2 v2.17 ​(Li 2018)​ for Illumina data, 
and  BWA or minimap2 (default) for ONT data. The SARS-CoV-2 Wuhan Hu-1 NCBI RefSeq genome, 
NC_045512.2​, is used as the reference by default ​(Wu et al. 2020)​, but have slightly modified the RefSeq 
sequence by removing the 33 nucleotide poly A tail from the 3’ end of the genome. Users can also specify any 
additional SARS-CoV-2 genome sequence available from GenBank, or upload a user-specific sequence as 
reference. To provide high quality consensus genomes, the default behavior is to use stringent parameters 
(Figure 1). Most of these parameters can be altered by the users. SNP and variant calling are provided by 
SAMtools v1.10 and BCFtools v1.10.2 ​(Li et al. 2009)​, followed by vcfutils.pl within SAMtools to further 
reduce false positive calls and filter the raw variant calls (​see online documentation​ for detailed parameters). 
Outputs of this workflow includes statistics for each series of analyses (in both graphical and tabular forms) 
and the results page for each dataset provides the interactive genome browser JBrowse ​(Buels et al. 2016)​, to 
enable a deeper, visual inspection of the variant calls and underlying data. Finally, EDGE COVID-19 provides 
an optional automated submission (see below) of the consensus genome sequence (together with required 
metadata input by the users) to GISAID, which can be performed after viewing the results.  
Calling a Consensus Genome 
Additional filtering steps after read mapping has been implemented based on how the samples were 
sequenced. For sequences generated using a shotgun approach, we first remove duplicate PCR sequences 
(​samtools markdup -r​), filter out low quality mapped reads based on MAPping Quality score (<60), base 
quality (<20 for Illumina and <7 for ONT), Base Alignment Quality for Illumina ​(Li 2011)​, and to alleviate 
memory constraints, further subsample to 8000X coverage (​samtools mpileup --max-depth 8000​) before 
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calling the consensus genome. For samples generated using amplicon based protocols from ARTIC and CDC 
(Paden et al. 2020)​, we trim the primers using ​align_tri​m (​Quick J et al. 2017​), and further process similar to 
shotgun data but without removing PCR duplicates. The workflow then calls gaps, ambiguous positions, and 
nucleotides in the consensus genome. When a BED file containing primer information is supplied for 
align_trim​, an interactive graphical summary of abundance of each amplicon is presented, allowing users to 
identify when and where amplicon dropouts have occurred.  
If no reads are mapped to a position, a gap is called (indicated by a lower-case n), while if a position is 
covered by less than five reads, an upper-case N is placed in that position. For any position that has more than 
five mapped reads, we further check the proportion of reads that either agree or disagree with the reference 
genome. Any nucleotide (or deletion) found in greater than 50% of all mapped reads is called as the consensus 
(there is a minimum of 5 reads that must agree), otherwise the position is also deemed ambiguous and an 
upper-case N is called. For ONT datasets, we implemented a more stringent threshold for indels at 80% to 
account for a higher frequency of these errors, particularly within homopolymeric nucleotide stretches ​(Rang 
et al. 2018; Cretu Stancu et al. 2017)​. All parameters can be adjusted within the web interface. 
Optional data trimming and removal 
Human host sequence screening is provided as an option. All input reads are mapped against the 
human reference genome GRCh38 using minimap2 and the reads that match at or above 80% identity (default 
settings) are removed prior to downstream processing​.​ A human-filtered file is also made available if raw data 
without human reads are needed. For an amplicon sequencing experiment, such as the one employed in the 
ARTIC protocol, the option to remove primers before downstream processing is also available. We have 
provided two options to remove primers, one requires a file of primer sequences and searches the 5’ end of 
reads for trimming, while the second one requires a BED file containing the amplicon positions and 
implements ​align_trim​ to soft clip the primers from each amplicon set.  
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 Optional ​de novo​ assembly 
EDGE COVID-19 also provides​ de novo​ assembly of sequencing reads and the annotation of 
genomes, but these features are disabled by default (since genome consensus generation from read alignment 
to a reference sequence has been the ​de facto​ approach with viral outbreaks). For exploratory investigations, 
the assembly module comes equipped with multiple ​de novo​ assemblers for both short (Illumina) and long 
(ONT) read datasets. As these assemblers have been designed for shotgun sequencing approaches, it is worth 
noting that amplicon protocols often do not result in single contigs spanning the entire length of the viral 
genome. Once invoked, the assembled contigs are also aligned to the selected reference genome using 
NUCmer, and SNPs, indels and gaps are also reported from these alignments. The assembled contigs can also 
be annotated by transferring the annotation from the ​NC_045512.2​ SARS-CoV-2 reference genome sequence 
(Otto et al. 2011)​.  
Optional data submission 
Once the consensus and supporting read evidence have been viewed, owners of the project are able to 
submit the genome directly from the platform to GISAID (see documentation for more details). Several 
criteria must be met in order for owners to have the option for automatic genome submission: genomes must 
have a length greater than 25kb, where at least 95% of the genome have assigned nucleotides (and not simply 
ambiguities or gap n’s), and the genome must have at least a ten-fold  average depth of coverage. One step in 
the genome submission process involves filling in metadata that is required by GISAID. Because of the strict 
nature and limited fields for the metadata submission process to GISAID, information on consensus 
generation, including the thresholds used to report nucleotides and SNPs are included in the Assembly method 
field. We strongly encourage the inclusion of as much contextual data as possible and recommend following 
the guidelines outlined within the ​SPHERES consortium’s data standards​ and a related Public Health Alliance 
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for Genomic Epidemiology (​PHA4GE​) effort. A similar, automated, option for GenBank and SRA submission 
are also under development, and are envisioned as a future feature of the platform. 
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Figure 1: EDGE COVID-19 workflow. ​The workflow takes in FASTQ files from Illumina or ONT and                
processes the data to produce a genome ready for repository submission. Dashed line indicates optional steps. 
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